China A-share innovative-drug sector extended gains; Puluo Pharmaceutical hit the daily trading limit. Earlier Ruikang Pharmaceutical, Baipusaisi, Harbin Pharmaceutical and Hisun Pharmaceutical also hit daily limits. Betta Pharmaceutical, Haofan Biotech and Haoyuan Pharmaceutical advanced.